Koninklijke Financial Statements From 2010 to 2025
| RYLPF Stock | USD 26.70 0.77 2.97% |
Check Koninklijke Philips financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Koninklijke Philips' main balance sheet or income statement drivers, such as , as well as many indicators such as . Koninklijke financial statements analysis is a perfect complement when working with Koninklijke Philips Valuation or Volatility modules.
Koninklijke |
Koninklijke Philips NV Company Return On Equity Analysis
Koninklijke Philips' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Koninklijke Philips Return On Equity | -0.12 |
Most of Koninklijke Philips' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke Philips NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Koninklijke Philips NV has a Return On Equity of -0.1166. This is 99.51% lower than that of the Healthcare sector and 98.66% lower than that of the Medical Devices industry. The return on equity for all United States stocks is 62.39% lower than that of the firm.
Koninklijke Philips Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Koninklijke Philips's current stock value. Our valuation model uses many indicators to compare Koninklijke Philips value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Koninklijke Philips competition to find correlations between indicators driving Koninklijke Philips's intrinsic value. More Info.Koninklijke Philips NV is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Koninklijke Philips' earnings, one of the primary drivers of an investment's value.About Koninklijke Philips Financial Statements
Koninklijke Philips stakeholders use historical fundamental indicators, such as Koninklijke Philips' revenue or net income, to determine how well the company is positioned to perform in the future. Although Koninklijke Philips investors may analyze each financial statement separately, they are all interrelated. For example, changes in Koninklijke Philips' assets and liabilities are reflected in the revenues and expenses on Koninklijke Philips' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Koninklijke Philips NV. Please read more on our technical analysis and fundamental analysis pages.
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands. KONINKLIJKE PHILIPS operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 78189 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Additional Information and Resources on Investing in Koninklijke Pink Sheet
When determining whether Koninklijke Philips is a strong investment it is important to analyze Koninklijke Philips' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Koninklijke Philips' future performance. For an informed investment choice regarding Koninklijke Pink Sheet, refer to the following important reports:Check out the analysis of Koninklijke Philips Correlation against competitors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.